Euclidean Capital as of Dec. 31, 2022
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 11 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Msci India Etf (INDA) | 22.5 | $24M | 577k | 41.74 | |
| 23andme Holding Class A Com (ME) | 20.7 | $22M | 10M | 2.16 | |
| Pmv Pharmaceuticals (PMVP) | 19.0 | $20M | 2.3M | 8.70 | |
| Alector (ALEC) | 8.5 | $9.1M | 981k | 9.23 | |
| Rapt Therapeutics (RAPT) | 8.0 | $8.6M | 433k | 19.80 | |
| Foghorn Therapeutics (FHTX) | 7.5 | $8.0M | 1.3M | 6.38 | |
| Oric Pharmaceuticals (ORIC) | 4.1 | $4.4M | 748k | 5.89 | |
| First Financial Ban (FFBC) | 3.9 | $4.2M | 174k | 24.23 | |
| Ngm Biopharmaceuticals (NGM) | 3.5 | $3.7M | 747k | 5.02 | |
| Tenaya Therapeutics (TNYA) | 1.7 | $1.8M | 916k | 2.01 | |
| Surrozen | 0.4 | $467k | 803k | 0.58 |
